Skip to main content

Table 1 Membership of the scientific board and Delphi respondents

From: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

Participating expertsNumberSpecialty, n (%)Hospital-based, n (%)1University-based, n (%)1Geographical origin, n (%)
Scientific board10Rheumatology, 9 (90)
Pediatrics, 1 (10)
6 (60)8 (80)Northern Italy, 7 (70)
Central Italy, 2 (20)
Southern Italy, 1 (10)
Bibliographic board4Rheumatology (100)2 (50)3 (75)Northern Italy, 3 (75)
Central Italy, 1 (25)
Delphi respondents49Rheumatology (100)22 (45)43 (88)Northern Italy, 20 (41)
Central Italy, 18 (37)
Southern Italy, 11 (22)
  1. 1Percentages do not add to 100 because some experts are both hospital- and university-based